These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 28471955)

  • 1. Serum VEGF-C levels as a candidate biomarker of hypervolemia in chronic kidney disease.
    Sahutoglu T; Sakaci T; Hasbal NB; Ahbap E; Kara E; Sumerkan MC; Sevinc M; Akgol C; Koc Y; Basturk T; Unsal A
    Medicine (Baltimore); 2017 May; 96(18):e6543. PubMed ID: 28471955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. N-terminal pro brain natriuretic peptide predicts mortality in patients with end-stage renal disease in hemodialysis.
    Madsen LH; Ladefoged S; Corell P; Schou M; Hildebrandt PR; Atar D
    Kidney Int; 2007 Mar; 71(6):548-54. PubMed ID: 17299526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic value of N-terminal pro-B-type natriuretic peptide (NT-proBNP) for left ventricular dysfunction in patients with chronic kidney disease stage 5 on haemodialysis.
    David S; Kümpers P; Seidler V; Biertz F; Haller H; Fliser D
    Nephrol Dial Transplant; 2008 Apr; 23(4):1370-7. PubMed ID: 18089624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigation of optimum N-terminal probrain natriuretic peptide level in patients on maintained hemodialysis.
    Chen L; Chen YY; Ling YS; Lin CH; He JX; Guan TJ
    Ren Fail; 2017 Nov; 39(1):372-378. PubMed ID: 28209075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical significance of N-terminal Pro-B-type natriuretic peptide (NT-proBNP) in hemodialysis patients.
    Helal I; Belhadj R; Mohseni A; Bazdeh L; Drissa H; Elyounsi F; Abdallah TB; Abdelmoula J; Kheder A
    Saudi J Kidney Dis Transpl; 2010 Mar; 21(2):262-8. PubMed ID: 20228511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relationship between chronic volume overload and elevated blood pressure in hemodialysis patients: use of bioimpedance provides a different perspective from echocardiography and biomarker methodologies.
    Voroneanu L; Cusai C; Hogas S; Ardeleanu S; Onofriescu M; Nistor I; Prisada O; Sascau R; Goldsmith D; Covic A
    Int Urol Nephrol; 2010 Sep; 42(3):789-97. PubMed ID: 20521167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of NT-proBNP levels in hemodialysis versus peritoneal dialysis patients.
    Ludka O; Spinar J; Tomandl J; Konecny T
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2013 Dec; 157(4):325-30. PubMed ID: 23154540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum asymmetric-dimethylarginine, apelin and NT-pro BNP levels in dialysis patients.
    Bentli R; Taskapan H; Taskapan MC; Dogan A
    Niger J Clin Pract; 2020 Nov; 23(11):1542-1547. PubMed ID: 33221779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma myeloperoxidase, NT-proBNP, and troponin-I in patients on CAPD compared with those on regular hemodialysis.
    Al-Hweish A; Sultan SS; Mogazi K; Elsammak MY
    Hemodial Int; 2010 Jul; 14(3):308-15. PubMed ID: 20597992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-terminal-pro-B-type-natriuretic peptide associated with 2-year mortality from both cardiovascular and non-cardiovascular origins in prevalent chronic hemodialysis patients.
    Kawagoe C; Sato Y; Toida T; Nakagawa H; Yamashita Y; Fukuda A; Iwatsubo S; Fujimoto S
    Ren Fail; 2018 Nov; 40(1):127-134. PubMed ID: 29457529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The relationship between serum level of N-terminal pro-B-type natriuretic peptide and nutritional status, and inflammation in chronic hemodialysis patients.
    Bednarek-Skublewska A; Zaluska W; Ksiazek A
    Clin Nephrol; 2010 Jan; 73(1):14-20. PubMed ID: 20040347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brain natriuretic peptide and N-terminal proBNP in chronic haemodialysis patients.
    Racek J; Králová H; Trefil L; Rajdl D; Eiselt J
    Nephron Clin Pract; 2006; 103(4):c162-72. PubMed ID: 16645318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aminoterminal B-type natriuretic peptide (NT-proBNP) in end-stage renal failure patients on regular hemodialysis: does it have diagnostic and prognostic implications?
    Pimenta J; Sampaio F; Martins P; Carvalho B; Rocha-Gonçalves F; Ferreira A; Bettencourt P
    Nephron Clin Pract; 2009; 111(3):c182-8. PubMed ID: 19194108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prohormone brain natriuretic peptide (proBNP), BNP and N-terminal-proBNP circulating levels in chronic hemodialysis patients. Correlation with ventricular function, fluid removal and effect of hemodiafiltration.
    Bargnoux AS; Klouche K; Fareh J; Barazer I; Villard-Saussine S; Dupuy AM; Leray-Moragues H; Giuliani I; Canaud B; Cristol JP
    Clin Chem Lab Med; 2008; 46(7):1019-24. PubMed ID: 18624622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between C-reactive protein levels and N-terminal pro-B-type natriuretic peptide in pre-dialysis patients.
    Ortega O; Gallar P; Muñoz M; Rodríguez I; Carreño A; Ortiz M; Molina A; Oliet A; Lozano L; Vigil A
    Nephron Clin Pract; 2004; 97(4):c125-30. PubMed ID: 15331941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vascular endothelial growth factor C levels are modulated by dietary salt intake in proteinuric chronic kidney disease patients and in healthy subjects.
    Slagman MC; Kwakernaak AJ; Yazdani S; Laverman GD; van den Born J; Titze J; Navis G
    Nephrol Dial Transplant; 2012 Mar; 27(3):978-82. PubMed ID: 21778278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The level of NT-proBNP in ambulatory patients with chronic heart failure with preserved ejection fraction of the left ventricle.
    Kirillova VV; Sokolova LA; Meshchaninov VN; Pershanova VI
    Ter Arkh; 2018 Sep; 90(9):68-72. PubMed ID: 30701738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adropin and irisin: New biomarkers of cardiac status in patients with end-stage renal disease? A preliminary study.
    Kałużna M; Pawlaczyk K; Schwermer K; Hoppe K; Człapka-Matyasik M; Ibrahim AY; Sawicka-Gutaj N; Minczykowski A; Ziemnicka K; Oko A; Ruchała M
    Adv Clin Exp Med; 2019 Mar; 28(3):347-353. PubMed ID: 30525316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CA 125 levels and left ventricular function in patients with end-stage renal disease on maintenance hemodialysis.
    Yilmaz H; Gürel OM; Celik HT; Sahiner E; Yildirim ME; Bilgiç MA; Bavbek N; Akcay A
    Ren Fail; 2014 Mar; 36(2):210-6. PubMed ID: 24289262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Independent and incremental prognostic value of novel cardiac biomarkers in chronic hemodialysis patients.
    Obokata M; Sunaga H; Ishida H; Ito K; Ogawa T; Ando Y; Kurabayashi M; Negishi K
    Am Heart J; 2016 Sep; 179():29-41. PubMed ID: 27595677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.